Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00467051 · OUTCOME

The Number of Patients Who Experience at Least One Grade 3 or Higher CTC Version 4 Toxicity.

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors · Source last updated 2018-08-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Two cycles of chemotherapy; expected to be 42 days of treatment.

Analysis population: All eligible patients.

Groups in this outcome

Experimental

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Experimental20

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Experimental18Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        18
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
groups
  1. id
    OG000
    title
    Experimental
param Type
COUNT_OF_PARTICIPANTS
population Description
All eligible patients.
reporting Status
POSTED
time Frame
Two cycles of chemotherapy; expected to be 42 days of treatment.
title
The Number of Patients Who Experience at Least One Grade 3 or Higher CTC Version 4 Toxicity.
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice